Search research articles
Contact Us
Filters
Showing results (211-220 of 252) with videos related to
Page
of 26
Sort By:
Journal of Affective Disorders
|
August 14, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy
Raymond W Lam, Sidney H Kennedy, Sophie Grigoriadis, et al.
The International Journal of Neuropsychopharmacology
|
May 28, 2015
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
Xinyu Zhou, Gabor I Keitner, Bin Qin, et al.
Poultry Science
|
February 1, 2022
Modeling improvements in ileal digestible amino acids by a novel consensus bacterial 6-phytase variant in broilers
Y Dersjant-Li, A Bello, T Stormink, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 23, 2020
Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1
Shane J McInerney, Trisha Chakrabarty, Malgorzata Maciukiewicz, et al.
The Journal of Clinical Psychiatry
|
April 29, 2015
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis
Xinyu Zhou, Arun V Ravindran, Bin Qin, et al.
Journal of Affective Disorders
|
December 18, 2021
Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study report
Yuelee Khoo, Ilya Demchenko, Benicio N Frey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly
Glenda M MacQueen, Benicio N Frey, Zahinoor Ismail, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 9, 2021
Prevalence and correlates of suicidal ideation among the general population in China during the COVID-19 pandemic
Le Shi, Jian-Yu Que, Zheng-An Lu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments
Sagar V Parikh, Lena C Quilty, Paula Ravitz, et al.
Molecular Psychiatry
|
April 22, 2018
Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents
Xinyu Zhou, Lanxiang Liu, Xinghui Lan, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 252) with videos related to
Sort By:
Page
of 26
Journal of Affective Disorders
|
August 14, 2009
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy
Raymond W Lam, Sidney H Kennedy, Sophie Grigoriadis, et al.
The International Journal of Neuropsychopharmacology
|
May 28, 2015
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
Xinyu Zhou, Gabor I Keitner, Bin Qin, et al.
Poultry Science
|
February 1, 2022
Modeling improvements in ileal digestible amino acids by a novel consensus bacterial 6-phytase variant in broilers
Y Dersjant-Li, A Bello, T Stormink, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 23, 2020
Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Professionnel Durant Le Traitement Par Escitalopram Chez Des Patients Souffrant De Trouble Dépressif Majeur: Une Étude Can-Bind-1
Shane J McInerney, Trisha Chakrabarty, Malgorzata Maciukiewicz, et al.
The Journal of Clinical Psychiatry
|
April 29, 2015
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis
Xinyu Zhou, Arun V Ravindran, Bin Qin, et al.
Journal of Affective Disorders
|
December 18, 2021
Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study report
Yuelee Khoo, Ilya Demchenko, Benicio N Frey, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly
Glenda M MacQueen, Benicio N Frey, Zahinoor Ismail, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
March 9, 2021
Prevalence and correlates of suicidal ideation among the general population in China during the COVID-19 pandemic
Le Shi, Jian-Yu Que, Zheng-An Lu, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments
Sagar V Parikh, Lena C Quilty, Paula Ravitz, et al.
Molecular Psychiatry
|
April 22, 2018
Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents
Xinyu Zhou, Lanxiang Liu, Xinghui Lan, et al.
Page
of 26